The Africa Centres for Disease Control and Prevention (Africa CDC) has officially endorsed a new mpox test developed in Morocco, marking a key advancement in Africa’s response to the ongoing outbreak. The newly approved real-time PCR test is capable of detecting the mpox virus DNA in blood, saliva, and tissue samples, making it a significant tool in improving public health efforts across the continent. This endorsement is a part of the African Union’s broader goal to strengthen Africa’s self-reliance in managing health emergencies and tackling emerging diseases.
The Africa CDC’s backing of Morocco’s test follows the organization’s declaration of the mpox outbreak as a public health emergency three months ago. Mpox, formerly known as monkeypox, has been spreading through close physical contact and infected animals, leading to symptoms like fever, muscle aches, and characteristic skin lesions. The endorsement enhances Africa’s ability to track and control the virus, complementing other diagnostic solutions like the WHO-approved Alinity m MPXV assay by Abbott Molecular.
This year, mpox has led to over 50,000 cases and approximately 1,100 deaths across Africa, with Central Africa experiencing the highest number of infections and fatalities.
NEWS DESK
PRESS UPDATE